These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 34249701)
1. Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma. Cheng Y; Hou K; Wang Y; Chen Y; Zheng X; Qi J; Yang B; Tang S; Han X; Shi D; Wang X; Liu Y; Hu X; Che X Front Oncol; 2021; 11():665276. PubMed ID: 34249701 [TBL] [Abstract][Full Text] [Related]
2. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma. Wu P; Zheng Y; Wang Y; Wang Y; Liang N J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329 [TBL] [Abstract][Full Text] [Related]
3. Identification of a three-gene expression signature and construction of a prognostic nomogram predicting overall survival in lung adenocarcinoma based on TCGA and GEO databases. Zhou Y; Gao S; Yang R; Du C; Wang Y; Wu Y Transl Lung Cancer Res; 2022 Jul; 11(7):1479-1496. PubMed ID: 35958325 [TBL] [Abstract][Full Text] [Related]
4. Identification of a novel gene expression signature associated with overall survival in patients with lung adenocarcinoma: A comprehensive analysis based on TCGA and GEO databases. Zhao J; Guo C; Ma Z; Liu H; Yang C; Li S Lung Cancer; 2020 Nov; 149():90-96. PubMed ID: 33002836 [TBL] [Abstract][Full Text] [Related]
5. A signature of tumor DNA repair genes associated with the prognosis of surgically-resected lung adenocarcinoma. Yang X; Wang G; Gu R; Xu X; Zhu G PeerJ; 2020; 8():e10418. PubMed ID: 33304656 [TBL] [Abstract][Full Text] [Related]
6. Development of metastasis-associated seven gene signature for predicting lung adenocarcinoma prognosis using single-cell RNA sequencing data. He J; Zhang W; Li F; Yu Y Math Biosci Eng; 2021 Jul; 18(5):5959-5977. PubMed ID: 34517518 [TBL] [Abstract][Full Text] [Related]
7. Nonnegative matrix factorization-based bioinformatics analysis reveals that TPX2 and SELENBP1 are two predictors of the inner sub-consensuses of lung adenocarcinoma. Wang H; Wang X; Xu L; Cao H; Zhang J Cancer Med; 2021 Dec; 10(24):9058-9077. PubMed ID: 34734491 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of pyroptosis-related factors in lung adenocarcinoma. Lin X; Zhou T; Hu S; Yang L; Yang Z; Pang H; Zhou X; Zhong R; Fang X; Yu Z; Hu K J Thorac Dis; 2022 Mar; 14(3):654-667. PubMed ID: 35399245 [TBL] [Abstract][Full Text] [Related]
9. Identification of a six-gene metabolic signature predicting overall survival for patients with lung adenocarcinoma. Cao Y; Lu X; Li Y; Fu J; Li H; Li X; Chang Z; Liu S PeerJ; 2020; 8():e10320. PubMed ID: 33344071 [TBL] [Abstract][Full Text] [Related]
10. A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD). Al-Dherasi A; Huang QT; Liao Y; Al-Mosaib S; Hua R; Wang Y; Yu Y; Zhang Y; Zhang X; Huang C; Mousa H; Ge D; Sufiyan S; Bai W; Liu R; Shao Y; Li Y; Zhang J; Shi L; Lv D; Li Z; Liu Q Cancer Cell Int; 2021 Jun; 21(1):294. PubMed ID: 34092242 [TBL] [Abstract][Full Text] [Related]
11. Genome‑wide investigation of the clinical significance and prospective molecular mechanisms of kinesin family member genes in patients with lung adenocarcinoma. Zhang L; Zhu G; Wang X; Liao X; Huang R; Huang C; Huang P; Zhang J; Wang P Oncol Rep; 2019 Sep; 42(3):1017-1034. PubMed ID: 31322267 [TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma. Tian Q; Zhou Y; Zhu L; Gao H; Yang J Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361 [No Abstract] [Full Text] [Related]
14. Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma. Zhao Z; He B; Cai Q; Zhang P; Peng X; Zhang Y; Xie H; Wang X Int Immunopharmacol; 2021 Sep; 98():107807. PubMed ID: 34175739 [TBL] [Abstract][Full Text] [Related]
15. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma. Zou X; Hu Z; Huang C; Chang J Med Sci Monit; 2020 Jul; 26():e924269. PubMed ID: 32613949 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive Analysis of Immune Implication and Prognostic Value of Zeng Y; Zhang Z; Chen H; Fan J; Yuan W; Li J; Zhou S; Liu W Front Oncol; 2021; 11():798425. PubMed ID: 35047409 [TBL] [Abstract][Full Text] [Related]
17. Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism-related genes. Wang Z; Embaye KS; Yang Q; Qin L; Zhang C; Liu L; Zhan X; Zhang F; Wang X; Qin S Cancer Cell Int; 2021 Apr; 21(1):219. PubMed ID: 33858449 [TBL] [Abstract][Full Text] [Related]
18. Identification of a novel autophagy signature for predicting survival in patients with lung adenocarcinoma. Duan J; Lei Y; Lv G; Liu Y; Zhao W; Yang Q; Su X; Song Z; Lu L; Shi Y PeerJ; 2021; 9():e11074. PubMed ID: 33976960 [TBL] [Abstract][Full Text] [Related]
19. A Robust 8-Gene Prognostic Signature for Early-Stage Non-small Cell Lung Cancer. He R; Zuo S Front Oncol; 2019; 9():693. PubMed ID: 31417870 [No Abstract] [Full Text] [Related]
20. Development and validation of a novel epigenetic-related prognostic signature and candidate drugs for patients with lung adenocarcinoma. Wang Z; Embaye KS; Yang Q; Qin L; Zhang C; Liu L; Zhan X; Zhang F; Wang X; Qin S Aging (Albany NY); 2021 Jul; 13(14):18701-18717. PubMed ID: 34285141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]